ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1,3,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
2,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
5,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
5,6,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,Y
5,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
6,3,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
6,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
7,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
7,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
8,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
8,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
8,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
8,4,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
10,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
11,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
12,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
13,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
13,2,Headache,Headaches NEC,Headaches,Nerv,N
13,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
14,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
14,3,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
15,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
16,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
17,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
17,2,Headache,Headaches NEC,Headaches,Nerv,N
17,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
19,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
20,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
20,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
21,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
22,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
22,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
23,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
24,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
24,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
24,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
25,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
27,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
28,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
31,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
32,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
32,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
32,4,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
33,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
33,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,3,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
34,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
34,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
35,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Lipid metabolism disorder,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
35,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
36,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
37,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
37,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
37,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
37,5,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
38,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
38,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
38,3,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
39,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
39,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
39,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
40,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
40,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
41,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
41,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
41,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
42,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
43,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
43,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
44,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
46,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,2,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
46,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
47,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
48,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
49,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
49,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
50,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
50,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
50,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
51,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
51,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
51,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
52,1,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
52,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
52,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
52,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
53,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
53,2,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
54,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
54,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
55,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
55,2,Epididymal cyst,Testicular and epididymal neoplasms,Testicular and epididymal disorders,Repro,N
55,3,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
55,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
56,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
57,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
57,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
57,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
57,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
57,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
57,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,2,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
58,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
59,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
59,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
60,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
61,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,2,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
62,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
63,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
64,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
64,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
65,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
66,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
66,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
67,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
67,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
68,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
68,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
69,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
70,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
70,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
71,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
72,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
72,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
72,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
73,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
74,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
74,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
75,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
76,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
76,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
77,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
77,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
78,1,Pancreatic pseudocyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
78,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
79,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
79,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
79,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
79,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
81,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
81,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
81,3,Cystitis ulcerative,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
81,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
81,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
81,6,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
81,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
82,1,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
83,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
83,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
84,1,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
84,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
85,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
85,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
85,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
85,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
86,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
87,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
88,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
88,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
89,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
90,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
90,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
91,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
92,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
92,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
92,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
93,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
94,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,2,Pancreatic pseudocyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
95,1,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
96,1,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
96,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
97,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
97,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,3,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
97,4,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
97,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
98,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
98,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
99,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
100,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
100,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
101,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
101,2,Headache,Headaches NEC,Headaches,Nerv,N
101,3,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
101,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
101,5,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
101,6,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
102,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
102,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
102,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
103,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
103,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
104,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
105,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
106,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
106,3,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
107,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
108,1,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
109,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
111,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
111,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,3,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
112,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
112,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,1,Paraesthesia mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
114,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
114,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
114,3,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
114,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
114,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
114,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
114,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
114,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
115,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
115,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
116,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
117,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
117,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
118,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
118,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
119,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
120,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
120,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
120,3,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
121,1,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
122,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
123,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
123,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
124,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
124,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
124,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
124,4,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
124,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
125,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
125,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
125,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
125,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
126,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
127,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
127,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
127,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
128,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
128,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
128,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
128,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
128,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
128,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
129,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
130,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
130,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
130,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
131,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
132,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
132,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
132,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
133,1,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
133,2,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
133,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
134,1,Alpha 1 foetoprotein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
134,2,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
135,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
135,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Alpha 1 foetoprotein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
136,2,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
137,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
139,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
139,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
139,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
139,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
139,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
139,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
139,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
139,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
139,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,1,Acne,Acnes,Skin appendage conditions,Skin,N
140,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
140,3,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
140,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
140,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,7,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
141,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
141,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,5,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
142,1,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
143,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
143,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
144,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
144,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
145,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
145,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
145,5,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
146,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
146,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
146,4,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
147,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
147,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
147,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
148,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
148,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
148,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
148,4,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
148,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
150,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
151,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
152,1,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
152,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
152,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
153,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
153,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
154,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
154,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
154,3,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
154,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
155,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
156,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
156,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
156,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
156,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
156,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
157,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
157,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
157,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
158,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
158,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
158,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
158,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
158,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
158,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
159,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
159,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
159,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
159,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
159,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
159,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
160,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
161,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
